Tricin reduces ROS production in endothelial cells, leading to downregulation of vascular endothelial growth factor receptor 2 (VEGFR2) signaling and inhibition of HIF-1α accumulation in tumor cells, resulting in decreased expression of VEGF [71]. The gene discussed is KDR; the disease is neoplasm.